Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.0' has been added to the history. The entry for 'Revision: v3.4.3' has been removed.
    Difference
    0.1%
    Check dated 2026-03-22T21:37:49.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.3 and no longer displays Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-08T12:24:22.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision history updated: added entry v3.4.2 and removed entry v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T14:42:46.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new revision v3.4.1 was added to the history, and revision v3.4.0 was removed.
    Difference
    0.1%
    Check dated 2026-02-07T09:14:16.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a revision label (v3.4.0).
    Difference
    1.0%
    Check dated 2026-01-24T04:50:04.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the Record History, and the previous entry v3.3.3 was removed. This update affects only metadata and does not alter study content, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T03:20:58.000Z thumbnail image

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.